Global Spotlight: China
Each month in Global Spotlight we provide market access facts from the country spotlighted on the cover of Market Pathways' print issue. The March 2025 issue features the Great Hall of the People in Beijing, China.
Market Pathways covers the people, challenges, and opportunities impacting the global medtech regulatory, reimbursement, and policy communities. We invite you to explore our coverage. Think Strategically.
Subscribe Today
Each month in Global Spotlight we provide market access facts from the country spotlighted on the cover of Market Pathways' print issue. The March 2025 issue features the Great Hall of the People in Beijing, China.
Some hot topics were addressed in rules, guides, and consultations last month primarily in Europe and the UK, while US FDA largely sat out policy development efforts, outside of selective editing and deleting of documents, in the opening month of the Trump administration.
There finally seems to be an impetus for revising the MDR/IVDR among the EU’s legislative and regulatory bodies, according to MedTech Europe’s senior officials Oliver Bisazza and Petra Zoellner. They expect the process to take a few years but think that this time it might actually happen.